Peijia Medical, a China-based domestic medical device company focused on transcatheter valve therapeutics and neurovascular inter ...

Perfuze, an Ireland-based developer of catheters for interventional stroke care, announced it has received FDA 510(k) ...

March 19, 2026—iVascular announced 1-year results from the BARISTA clinical trial, which is evaluating the safety and efficacy of the company&rs ...

March 18, 2026—iVascular announced 3-year follow-up results from the LUMIFOLLOW registry, a large real-world study evaluating the safety and eff ...

Terumo Aortic announced that the FDA has granted Breakthrough Device designation for the company’s fenestrated Treo abdomin ...

Imperative Care, Inc., a developer of treatments for thromboembolic disease, announced the closing of a $100 million convertible ...

Boston Scientific announced FDA clearance for the “Any Day Dosing” feature on the company’s TheraSphere 360 ytt ...

Thrombolex, Inc., a commercial-stage developer of a differentiated pharmacomechanical lysis platform for the treatment of pulmona ...

Cook Medical announced it has selected Indiana University (IU) in Indianapolis, Indiana, as one of the first Interventional MRI ( ...

Three-year outcomes from the PERFORMANCE II trial studying the Neuroguard Integrated Embolic Protection (IEP) 3-in-1 Carotid Sten ...

VS3 Medical, Inc. announced it has commenced enrollment in an international first-in-human (FIH) study evaluating the VS3 Med ...

IceCure Medical Ltd. announced that the FDA has approved the study design for the ChoICE trial, the company’s postmarketing ...